New Features Announced with CellPort Software 2.5 Release

The All-in-One Lab Management Tool for Cell Culture, Cell Banking, and Cell Manufacturing

Philadelphia, PA- <September 08, 2022> – CellPort Software announced the release of their latest cloud-based, Software-as-a-Service (SaaS) product –  CellPort Version 2.5, with an extensive list of new features and digital capabilities that streamline cell culture, cell banking, and cell manufacturing for R&D, biotechnology, biopharmaceutical, and contract laboratory organizations. 

Offering a suite of digital tools on a secure, compliant platform, CellPort Software was developed to boost productivity and traceability, decrease data errors, improve data integrity, and simplify GMP and FDA compliance of cell-based laboratory and manufacturing processes. CellPort 2.5 includes updates and improvements to these four key modules:

• Equipment – Track all the equipment used in your facility, and automatically schedule events like calibration or maintenance, based on your business needs.

• Materials – Manage materials and in-house reagents, and set specifications for material handling, ingredients, and other necessary information. 

• Manufacturing – Boost capacity and scale operations with advanced cell lot and vial tracking, cell lineage tracing, storage container management, and dynamic master batch records. All processes are GLP and GMP compliant.

• Audit Reports – With a few clicks, CellPort generates documentation and analysis that auditors need to perform their duties, and leadership needs to make strategic decisions

Gregory M. Banik, Ph.D., VP of Operations at CellPort Software, commented, “We’re excited to contribute to the productivity and reproducibility of our clients. We’ve expanded our capabilities to make CellPort even more powerful and flexible so that it can readily meet the demands of our users.”

For more information on CellPort, visit www.cellportsoftware.com 

About CellPort Software

Founded in 2014, CellPort Software was conceived with a single goal in mind: to digitalize the cell manufacturing process. Today, CellPort boasts the most innovative set of cloud-based cell-manufacturing and laboratory execution applications in the life-sciences industry. Our SaaS-based application defines and manages all assay workflows, activities, equipment, materials, personnel, data/calculations, and projects used by CROs, CMOs, research institutions, bio-pharma companies, and regulatory authorities in assay development and biomanufacturing at all stages of development (R&D, GLP, GMP).